Pages

Showing posts with label Glenmark Pharma. Show all posts
Showing posts with label Glenmark Pharma. Show all posts

Glenmark Pharma up 3% on final ANDA nod for skin drug



Shares of Glen mark Parma surged 3.3 percent intraday Tuesday on receiving USFDA sanction for skin treatment by its US additional. "Glen mark Generics Inc, USA, the subsidiary of Glen mark Generics, has been settled final approval from the United States Food and Drug management (US FDA) for its condensed new drug application (ANDA) for Fluocinonide Cream USP 0.1 percent, the broad version of Vanes Cream by Medicos," says the company in its filing.

Fluocinonide Cream is indicated for the relief of the inflammatory and cleanliness manifestations of corticosteroid responsive dermatomes. "VANOS unguent is a instruction corticosteroid (steroid hormone) used on the skin (topical) to treat adults and children 12 years of age and older with confident skin conditions that cause red, flaky, and itchy skin," says Medicis. According to IMS Health sales data for the 12 month stage finish March 2014, Fluocinonide Cream garnered yearly sales of approximately USD 103 million. Glenmark’s current portfolio consists of 93 products authorised for allotment in the US marketplace and 71 ANDA’s pending approval with the US FDA. "In adding up to these internal filings, Glenmark Generics Inc continues to identify and explore external development partnerships to supplement and speed up the growth of the accessible pipeline and selection," it adds. At 10:36 hours IST, the stock was quoting at Rs 551.75, up 2.34 percent on the BSE.